GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E) » Definitions » Additional Paid-In Capital

Cybin (FRA:R7E) Additional Paid-In Capital : €29.68 Mil(As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Additional Paid-In Capital?


Cybin's quarterly additional paid-in capital increased from Dec. 2023 (€2.90 Mil) to Mar. 2024 (€7.99 Mil) and increased from Mar. 2024 (€7.99 Mil) to Jun. 2024 (€29.68 Mil).

Cybin's annual additional paid-in capital increased from Mar. 2022 (€0.38 Mil) to Mar. 2023 (€1.44 Mil) and increased from Mar. 2023 (€1.44 Mil) to Mar. 2024 (€7.99 Mil).


Cybin Additional Paid-In Capital Historical Data

The historical data trend for Cybin's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Additional Paid-In Capital Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Additional Paid-In Capital
- 0.08 0.38 1.44 7.99

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 2.58 2.90 7.99 29.68

Cybin Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Cybin Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Cybin's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin Business Description

Industry
Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin Headlines

No Headlines